drugset
drugset / Trial / NCT06739473

Total-body Glucose Utilization in Obesity

NCT06739473 ↗

Phase 4 Recruiting 60 enrolled Turku University Hospital
Non-randomizedParallel-groupSingle-blindBasic science

Summary

There are three goals for this study. One is to investigate how different emotions and exposure to cold affect blood flow in the body. The second aim is to study how insulin affects blood flow and tissue glucose uptake, and to study whether this effect is altered in obesity. Last, the study focuses on establishing the lowest dose of a PET radiotracer, oxygen-15 labelled water, that can be used in clinical studies with a new whole-body PET scanner.

Timeline

Start
2023-01-25
Primary completion
2024-12
Completion
2024-12

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin aspart Protein / enzyme biologic 1 unknown Intravenous
Background Glucose Unknown 20 % —

Indications

obesity disorder